Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Raymond James Financial, Inc. (RJF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Raymond James Financial, Inc. — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while Raymond James Financial, Inc. trades at $156.93 (market cap $30.15B). The key difference: Raymond James Financial, Inc. is far larger — about 5.9× Oruka Therapeutics Inc. Common Stock's market cap, and Raymond James Financial, Inc. pays a 1.38% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Raymond James Financial, Inc. for 75 Days on average.
| ORKA | RJF | |
|---|---|---|
Market Cap | $5.08B | $30.15B |
Volume | 685,276 | 980,106 |
Sector | Health | Financials |
52-Week High | $113.08 | $181.18 |
52-Week Low | $26.19 | $140.89 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $4.21B | $24.02B |
Dividend Yield | — | 1.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Raymond James Financial (RJF) trades at $156.78, down 1.18% with bearish technical indicators but strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $3.14 exceeding expectations. Revenue growth has been steady from $10.9B in 2022 to $13.8B in 2025, with net income margins above 15%. Recent leadership transitions and PGA TOUR sponsorship highlight strategic developments.
The outlook remains positive with a $178.50 consensus price target representing 14% upside potential. Analyst consensus leans Hold (55.56%) with no Sell ratings, indicating cautious optimism. Key risks include volatile cash flows from investing activities and brokerage market sensitivity. The company's strong profitability metrics and institutional accumulation support long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Raymond James Financial, Inc.
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →
